Moreover, NFKB1 has been reported to play a crucial role in attenuating the activation of the NF-κB signaling pathway, potentially revealing a new therapeutic target in inflammatory diseases and cancer (Cartwright et al., 2016). Here, NFKB1 is linked to cancer.